Clinical Trial: A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell)

U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07633197) titled 'A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell)' on June 03.

Brief Summary: To evaluate the safety and tolerability of different dosages of recombinant zoster vaccine (CHO cell) when administered to adults aged 40 years and older.

Study Start Date: May 28

Study Type: INTERVENTIONAL

Condition: Herpes

Intervention: BIOLOGICAL: Recombinant Herpes Zoster Vaccine

This product is for intramuscular injection only, with the deltoid muscle of the upper arm as the preferred vaccination site. The immunization schedule consists of two doses at 0.5 ml per dose, and the second dose shall be administered two months a...